Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer

AIM: To determine the efficacy of bevacizumab in patients with metastatic colorectal cancer (MCRC) who have failed prior chemotherapy without bevacizumab. METHODS: Between March 2002 and June 2010, 40 patients in South Korea with MCRC who were treated with bevacizumab plus chemotherapy as a second o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Park, Lee Chun, Lee, Ho Sup, Shin, Seong Hoon, Park, Seun Ja, Park, Moo In, Oh, Sung Yong, Kwon, Hyuk Chan, Baek, Jin ho, Choi, Young Jin, Kang, Myoung Joo, Kim, Yang Soo
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Co., Limited 2012
Matèries:
Brief Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3296985/
https://ncbi.nlm.nih.gov/pubmed/22416186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i10.1104
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars